Interestingly, PXR ablation in mice prevented HFD- and gene mutation–induced insulin resistance and hepatic steatosis [28] while severe spontaneous hepatic steatosis was observed in Pxr-KO mice [35], indicating that both the activation and depletion of PXR can induce the development of steatosis. The gene discussed is NR1I2; the disease is fatty liver disease.